GPS Wealth Strategies Group’s Acceleron Pharma XLRN Stock Holding History

GPS Wealth Strategies Group’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35	Closed	-$6K	–	1135
2021 Q3	$6K	Hold	35	–	–	﹤0.01%	822
2021 Q2	$4K	Hold	35	–	–	﹤0.01%	912
2021 Q1	$4K	Buy	+35	New	+$4.52K	﹤0.01%	809

GPS Wealth Strategies Group's XLRN Position: Q4 2021 in Review

GPS Wealth Strategies Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 35 shares — an estimated $6K sold.

GPS Wealth Strategies Group first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $6K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

GPS Wealth Strategies Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
GPS Wealth Strategies Group sold 35 Acceleron Pharma shares in Q4 2021, an estimated $6K.
GPS Wealth Strategies Group first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
GPS Wealth Strategies Group's Acceleron Pharma position peaked at $6K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2021, filed 11 Feb 2022.